Corbus Pharmaceuticals Holdings is an American clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company was founded in 2009 and is based in Norwood, Massachusetts.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Corbus Pharmaceuticals Holdings news
10.05.2022
Corbus Pharmaceuticals' GAAP loss for 3 months of 2022 was $9.437 million, down 41.3% from $16.065 million in the previous year. The company did not generate revenue in the period. In the same period last year, revenue was $647,824 thousand a year earlier.
Source: 
ir.corbuspharma.com
ir.corbuspharma.com
08.03.2022
Corbus Pharmaceuticals' GAAP loss for 2021 was $45.64 million, down 2.4 times from $111.269 million in the previous year. Revenue decreased 4.5 times to $0.882 million from $3.937 million a year earlier.
Source: ir.corbuspharma.com
ir.corbuspharma.com
15.11.2021
Corbus Pharmaceuticals Holdings' GAAP loss for 9M 2021 was $35.38 million, down 2.9 times from $102.658 million in the previous year. Revenue decreased 3.7 times to $0.882 million from $3.279 million a year earlier.
Source: ir.corbuspharma.com
ir.corbuspharma.com
12.08.2021
Corbus Pharmaceuticals' GAAP loss for 6M 2021 was $33.204 million, down 51% from $67.762 million in the previous year. Revenue decreased 61.7% to $0.784 million from $2.048 million a year earlier.
Source: ir.corbuspharma.com
ir.corbuspharma.com
General information
| Company name | Corbus Pharmaceuticals Holdings |
|---|---|
| Tags | #pharmacy, #biotechnology |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 500 River Ridge Drive Norwood, MA 02062 United States |
| Mailing address | 500 River Ridge Drive Norwood, MA 02062 United States |
| Website | ir.corbuspharma.com |
| Information disclosure | www.sec.gov |
English (US) 